Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 32,035,000 | 30,749,000 | 28,817,000 | 29,253,041 | 29,489,295 |
| Cost of Goods | 8,717,000 | 7,880,000 | 7,337,000 | 7,582,979 | 7,586,750 |
| Gross Profit | 23,318,000 | 22,869,000 | 21,480,000 | 21,670,063 | 21,902,545 |
| Operating Expenses | 15,985,000 | 15,051,000 | 15,579,000 | 15,612,459 | 15,898,609 |
| Operating Income | 7,333,000 | 7,818,000 | 5,901,000 | 6,057,604 | 6,003,936 |
| Interest Expense | 467,000 | 324,000 | 335,000 | N/A | N/A |
| Other Income | -1,267,000 | -1,428,000 | -1,404,000 | -276,406 | -1,256,250 |
| Pre-tax Income | 5,599,000 | 6,066,000 | 4,162,000 | 5,781,198 | 4,747,686 |
| Income Tax | 1,242,000 | 1,364,000 | 682,000 | 687,928 | 800,121 |
| Net Income Continuous | 5,335,000 | 5,516,000 | 4,733,000 | 5,271,597 | 4,005,907 |
| Net Income Discontinuous | 386,000 | 175,000 | N/A | N/A | N/A |
| Minority Interests | -254,000 | -426,000 | -441,000 | -419,752 | -393,241 |
| Net Income | $5,467,000 | $5,265,000 | $4,292,000 | $5,271,597 | $4,005,907 |
| EPS Basic Total Ops | 4.19 | 4.03 | 2.94 | 3.92 | 2.97 |
| EPS Basic Continuous Ops | 4.19 | 4.03 | 2.94 | 3.92 | 2.97 |
| EPS Diluted Total Ops | 4.18 | 4.03 | 2.94 | 3.90 | 2.95 |
| EPS Diluted Continuous Ops | 4.18 | 4.03 | 2.94 | 3.90 | 2.95 |
| EBITDA(a) | $11,195,000 | $11,401,000 | $10,482,000 | $10,729,064 | $12,116,978 |